CRDN

Views & Analysis

Tunnah’s musings: Rare diseases hold key to future of drug d...

The lessons that can be learned for the future of drug development from the collaboration and innovation in this space.

Views & Analysis

Rethinking rare diseases: treat the whole patient

CRDN wants to break down barriers in communication between rare disease patients, HCPs and industry.

News

NHS "isn't delivering equitable care for rare diseases"

A Genetic Alliance UK report claims the NHS is failing to meet the needs of many of the 3.5 million people in the country who live with rare diseases.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/register.png

Sales & Marketing

Using AI-driven synthetic personas to take your insights fur...

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.

Editor's Picks